Nifty
Sensex
:
:
15763.05
52586.84
-15.40 (-0.10%)
-66.23 (-0.13%)

Chemicals

Rating :
62/99

BSE: 532834 | NSE: CAMLINFINE

188.40
30-Jul-2021
  • Open
  • High
  • Low
  • Previous Close
  •  185.75
  •  192.40
  •  185.10
  •  186.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  767969
  •  1452.45
  •  230.80
  •  70.45

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,409.56
  • 47.28
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,809.12
  • N/A
  • 4.90

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 21.61%
  • 7.24%
  • 35.22%
  • FII
  • DII
  • Others
  • 5.28%
  • 18.04%
  • 12.61%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.48
  • 17.33
  • 9.99

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 20.46
  • 43.49
  • 20.70

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 29.37
  • -
  • 332.51

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.49
  • 22.48
  • 26.63

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.63
  • 3.00
  • 2.32

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 26.40
  • 37.09
  • 12.55

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Net Sales
326.62
292.87
11.52%
297.93
273.88
8.78%
256.81
222.28
15.53%
305.74
260.12
17.54%
Expenses
276.96
265.40
4.36%
251.15
244.33
2.79%
223.17
192.26
16.08%
254.67
224.57
13.40%
EBITDA
49.67
27.47
80.82%
46.77
29.55
58.27%
33.64
30.01
12.10%
51.08
35.56
43.64%
EBIDTM
15.21%
9.38%
15.70%
10.79%
13.10%
13.50%
16.71%
13.67%
Other Income
2.09
2.77
-24.55%
4.42
1.38
220.29%
1.28
0.64
100.00%
0.67
3.02
-77.81%
Interest
11.33
8.41
34.72%
10.02
8.28
21.01%
8.13
14.42
-43.62%
10.76
8.30
29.64%
Depreciation
11.83
9.13
29.57%
13.36
8.41
58.86%
9.63
7.68
25.39%
9.48
7.59
24.90%
PBT
28.60
12.71
125.02%
27.81
14.25
95.16%
17.17
8.56
100.58%
31.51
22.68
38.93%
Tax
12.89
10.65
21.03%
8.39
10.43
-19.56%
7.51
1.04
622.12%
10.95
6.25
75.20%
PAT
15.72
2.05
666.83%
19.42
3.83
407.05%
9.66
7.52
28.46%
20.56
16.43
25.14%
PATM
4.81%
0.70%
6.52%
1.40%
3.76%
3.38%
6.72%
6.32%
EPS
1.12
0.22
409.09%
1.21
0.43
181.40%
0.49
0.57
-14.04%
1.27
1.28
-0.78%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
-
1,187.10
1,049.15
892.17
720.60
533.93
489.34
558.27
508.67
373.62
335.25
Net Sales Growth
-
13.15%
17.60%
23.81%
34.96%
9.11%
-12.35%
9.75%
36.15%
11.45%
 
Cost Of Goods Sold
-
583.49
533.78
474.80
422.44
260.51
203.10
270.49
275.73
164.64
167.52
Gross Profit
-
603.62
515.37
417.36
298.16
273.42
286.24
287.78
232.94
208.98
167.73
GP Margin
-
50.85%
49.12%
46.78%
41.38%
51.21%
58.50%
51.55%
45.79%
55.93%
50.03%
Total Expenditure
-
1,000.36
913.94
819.26
705.95
503.23
397.55
474.10
449.20
327.56
306.22
Power & Fuel Cost
-
84.16
76.38
80.42
61.43
46.35
47.43
58.00
51.43
57.06
55.65
% Of Sales
-
7.09%
7.28%
9.01%
8.52%
8.68%
9.69%
10.39%
10.11%
15.27%
16.60%
Employee Cost
-
120.38
99.71
87.89
72.87
61.09
40.05
40.58
34.37
30.10
23.69
% Of Sales
-
10.14%
9.50%
9.85%
10.11%
11.44%
8.18%
7.27%
6.76%
8.06%
7.07%
Manufacturing Exp.
-
55.94
50.73
41.56
34.70
31.04
37.04
35.06
26.59
24.03
12.88
% Of Sales
-
4.71%
4.84%
4.66%
4.82%
5.81%
7.57%
6.28%
5.23%
6.43%
3.84%
General & Admin Exp.
-
41.92
50.25
44.15
36.86
38.28
24.72
21.21
17.36
17.74
11.76
% Of Sales
-
3.53%
4.79%
4.95%
5.12%
7.17%
5.05%
3.80%
3.41%
4.75%
3.51%
Selling & Distn. Exp.
-
54.42
50.02
46.92
39.48
33.48
25.33
20.17
17.78
15.00
6.73
% Of Sales
-
4.58%
4.77%
5.26%
5.48%
6.27%
5.18%
3.61%
3.50%
4.01%
2.01%
Miscellaneous Exp.
-
60.06
53.06
43.52
38.17
32.48
19.88
28.58
25.93
18.99
6.73
% Of Sales
-
5.06%
5.06%
4.88%
5.30%
6.08%
4.06%
5.12%
5.10%
5.08%
8.35%
EBITDA
-
186.74
135.21
72.91
14.65
30.70
91.79
84.17
59.47
46.06
29.03
EBITDA Margin
-
15.73%
12.89%
8.17%
2.03%
5.75%
18.76%
15.08%
11.69%
12.33%
8.66%
Other Income
-
10.79
3.43
13.79
12.91
15.65
4.27
8.38
11.84
11.16
11.84
Interest
-
48.14
47.63
40.95
31.80
30.58
24.44
23.82
24.66
20.11
16.69
Depreciation
-
44.29
32.80
28.99
26.65
21.80
17.06
16.25
11.79
13.61
13.51
PBT
-
105.10
58.20
16.75
-30.90
-6.03
54.57
52.48
34.86
23.51
10.67
Tax
-
39.74
28.37
13.69
-6.75
-1.58
14.20
-2.21
6.13
8.38
6.94
Tax Rate
-
37.81%
48.75%
81.73%
21.84%
26.20%
28.39%
-4.18%
17.58%
35.64%
64.14%
PAT
-
50.97
30.32
0.63
-29.81
-11.20
35.82
55.04
28.74
15.12
3.88
PAT before Minority Interest
-
65.36
29.83
3.06
-24.14
-4.46
35.82
55.04
28.74
15.12
3.88
Minority Interest
-
-14.39
0.49
-2.43
-5.67
-6.74
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
4.29%
2.89%
0.07%
-4.14%
-2.10%
7.32%
9.86%
5.65%
4.05%
1.16%
PAT Growth
-
68.11%
4,712.70%
-
-
-
-34.92%
91.51%
90.08%
289.69%
 
EPS
-
3.99
2.38
0.05
-2.34
-0.88
2.81
4.31
2.25
1.18
0.30

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
643.40
403.14
370.88
371.16
212.58
176.22
134.87
93.30
65.38
52.91
Share Capital
12.75
12.13
12.13
12.12
10.37
9.67
9.59
9.44
9.39
9.36
Total Reserves
579.24
390.57
336.37
336.62
200.53
166.55
125.19
83.66
55.90
43.45
Non-Current Liabilities
257.81
185.44
154.88
72.63
32.51
11.69
16.84
25.47
40.82
36.29
Secured Loans
179.11
176.24
189.02
104.63
47.51
21.45
28.06
28.52
30.72
26.02
Unsecured Loans
94.14
35.27
4.62
5.61
3.81
0.00
0.00
0.00
6.95
6.97
Long Term Provisions
2.83
2.85
2.37
1.96
2.14
1.85
1.47
0.98
0.00
0.00
Current Liabilities
477.63
547.83
460.39
470.91
385.72
279.94
261.53
245.88
263.28
196.40
Trade Payables
158.40
173.72
164.61
177.79
78.40
95.31
106.55
100.01
157.47
87.22
Other Current Liabilities
92.55
81.51
43.92
39.04
27.45
27.40
19.50
27.73
13.74
11.29
Short Term Borrowings
216.90
278.07
244.34
246.79
269.90
145.70
120.95
104.01
79.50
88.53
Short Term Provisions
9.78
14.53
7.52
7.29
9.97
11.53
14.53
14.13
12.57
9.36
Total Liabilities
1,448.59
1,193.38
1,045.55
976.92
648.42
467.85
413.24
364.65
369.48
285.60
Net Block
581.45
303.71
272.44
278.10
200.88
140.27
106.43
83.15
83.28
73.82
Gross Block
758.49
428.21
359.11
342.34
213.71
359.66
295.11
283.15
251.04
226.08
Accumulated Depreciation
177.04
124.50
86.67
64.24
12.82
219.38
188.69
199.99
167.76
152.27
Non Current Assets
653.90
518.42
373.07
311.37
229.03
168.13
114.54
107.90
86.28
78.66
Capital Work in Progress
23.82
178.78
59.00
13.62
7.62
25.06
2.82
22.08
0.76
2.23
Non Current Investment
9.43
9.43
7.28
7.33
7.16
1.09
1.09
1.21
1.23
1.24
Long Term Loans & Adv.
37.30
24.84
32.06
11.31
7.73
1.70
4.21
1.46
1.00
1.37
Other Non Current Assets
1.90
1.65
2.29
1.01
5.62
0.00
0.00
0.00
0.00
0.00
Current Assets
794.69
674.96
672.48
665.55
419.40
299.72
298.69
256.75
283.20
206.94
Current Investments
0.00
0.00
3.25
108.08
11.70
0.00
0.00
0.00
0.00
0.00
Inventories
320.00
298.15
285.41
239.02
197.80
173.32
136.38
109.20
149.00
84.36
Sundry Debtors
270.71
252.80
209.32
205.35
144.89
75.48
113.42
101.32
87.06
90.17
Cash & Bank
138.34
64.79
103.44
48.08
31.24
18.90
19.26
15.80
25.74
10.23
Other Current Assets
65.65
20.99
19.84
14.10
33.77
32.03
29.63
30.42
21.40
22.19
Short Term Loans & Adv.
41.85
38.22
51.21
50.92
20.77
20.16
14.87
17.56
19.66
19.61
Net Current Assets
317.06
127.12
212.09
194.64
33.68
19.78
37.16
10.87
19.92
10.54
Total Assets
1,448.59
1,193.38
1,045.55
976.92
648.43
467.85
413.23
364.65
369.48
285.60

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
117.38
86.02
-9.00
-15.41
-8.69
71.57
46.26
26.74
55.61
-31.86
PBT
105.10
58.20
16.69
-30.90
-6.03
50.02
52.48
34.86
23.51
10.67
Adjustment
114.15
86.98
70.35
40.90
46.70
48.89
47.26
40.28
32.66
26.51
Changes in Working Capital
-65.93
-41.25
-79.83
-15.27
-39.00
-15.14
-42.60
-38.73
5.83
-63.80
Cash after chg. in Working capital
153.32
103.94
7.22
-5.27
1.67
83.77
57.14
36.41
62.00
-26.62
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-35.93
-17.92
-16.22
-10.14
-10.36
-12.20
-10.88
-9.67
-6.39
-5.25
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-132.86
-90.12
-1.94
-148.59
-83.14
-65.67
-26.28
-32.16
-18.66
-9.21
Net Fixed Assets
-37.22
-149.41
-67.82
-7.46
57.11
-37.27
-23.68
-1.87
-12.66
-13.00
Net Investments
0.45
-7.12
79.12
-104.14
-37.24
-2.13
-0.77
-2.48
0.00
0.15
Others
-96.09
66.41
-13.24
-36.99
-103.01
-26.27
-1.83
-27.81
-6.00
3.64
Cash from Financing Activity
38.63
3.25
25.67
181.82
90.92
-6.87
-15.48
-6.29
-21.44
38.17
Net Cash Inflow / Outflow
23.15
-0.85
14.74
17.82
-0.92
-0.97
4.49
-11.71
15.51
-2.90
Opening Cash & Equivalents
52.37
53.21
38.48
20.65
8.03
8.99
4.50
16.21
10.23
13.13
Closing Cash & Equivalent
75.52
52.37
53.21
38.48
20.65
8.03
8.99
4.50
25.74
10.23

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
38.57
33.21
28.74
28.77
20.34
18.23
14.06
9.86
6.95
5.64
ROA
4.95%
2.66%
0.30%
-2.97%
-0.80%
8.13%
14.15%
7.83%
4.62%
1.65%
ROE
14.61%
7.94%
0.88%
-8.63%
-2.30%
23.04%
48.31%
36.29%
25.61%
7.82%
ROCE
15.25%
12.02%
7.32%
0.14%
5.45%
22.86%
28.50%
27.41%
23.65%
18.81%
Fixed Asset Turnover
2.00
2.67
2.54
2.60
1.91
1.54
1.97
1.94
1.60
1.55
Receivable days
80.48
80.39
84.82
88.44
73.54
68.37
68.69
66.48
84.48
75.55
Inventory Days
95.03
101.51
107.28
110.30
123.85
112.09
78.55
91.12
111.24
63.17
Payable days
66.82
72.27
77.53
73.54
64.72
89.70
89.36
114.87
132.61
84.56
Cash Conversion Cycle
108.69
109.63
114.57
125.19
132.67
90.76
57.88
42.72
63.10
54.15
Total Debt/Equity
1.09
1.31
1.32
1.07
1.57
1.02
1.19
1.61
1.93
2.36
Interest Cover
3.18
2.22
1.41
0.03
0.80
3.05
3.22
2.41
2.17
1.65

News Update:


  • Camlin Fine Sciences gets nod for strategic investment in AlgalR NutraPharms
    17th May 2021, 11:30 AM

    The Committee has also approved subscription to the equity shares of AlgalR

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.